Navigation Links
Phyhealth Signs Agreement with Argus Dental to Provide Dental Services for Pilot HMO
Date:5/8/2008

MIAMI, May 8 /PRNewswire-FirstCall/ -- Physicians Healthcare Management Group, Inc. (Phyhealth) (Pink Sheets: PHYH), a developer of health maintenance organizations (HMOs) in partnership with physicians, today announced that Phyhealth Plan Corporation, a wholly-owned subsidiary of Phyhealth, has signed an agreement with Argus Dental of Tampa, Florida to provide dental services for its Pilot HMO scheduled to be launched in the latter half of 2008.

Mr. Robert Trinka, chairman and chief executive officer, stated, "In keeping with our mandate to offer the highest quality, yet affordable healthcare to our members as we prepare to roll out our first Pilot HMO in the state of Florida, we are pleased to announce that Argus Dental has signed on as a provider of dental services. Argus' network consists of over 1,500 dental providers throughout Florida that have been credentialed according to the standards set forth by the National Committee for Quality Assurance and the Centers for Medicare and Medicaid Services. Argus' stringent screening process helps ensure that only the best dentists in the business are accepted into the plan. We are confident that members signing up for our Pilot HMO will receive the best care available to address their dental needs."

Dr. Nicholas Kavouklis, President and CEO of Argus Dental, commented, "Phyhealth shares our commitment to excellence and together we will provide comprehensive, yet affordable dental care in a community-based setting. A personalized, patient-centric approach to healthcare is beneficial and comforting to patients and we look forward to joining forces with Phyhealth as it brings its unique brand of healthcare to the Florida marketplace later this year."

About Physicians Healthcare Management Group, Inc.

Physicians Healthcare Management Group, Inc. (Phyhealth) is a developer of community-based health maintenance organizations (HMOs) that are owned and operated in partnership with the particip
'/>"/>

SOURCE Physicians Healthcare Management Group, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related medicine news :

1. Phyhealth Appoints Gerald H. Priceman as Medical Director
2. Phyhealth Signs Agreement with Advantica EyeCare to Provide Vision Services for Pilot HMO
3. Phyhealth Files Historical Financials With the Pink Sheets and Takes Next Step Toward Becoming Fully Reporting
4. Phyhealth HMO Applications Accepted by All Required Federal and State Agencies
5. Phyhealth Submits HMO Applications with Required Federal and State Agencies
6. Phyhealth Concludes $1.5 Million Financing for Launch of Its Pilot Community-Based HMO
7. AMDL Signs Letter of Intent to Purchase a China Based Pharmaceutical Distribution Company
8. Younger Women Often Miss Signs of Heart Attack
9. Some women more likely to miss or ignore heart attack warning signs
10. Governor Napolitano Signs Smoking Cessation Bill
11. AMDL Signs MOU for 200 Store Distribution Arrangements for Goodnak Product Line
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/16/2008)...eclaring that Primary care medicine is in a precip...of the American College of Physicians (ACP), today... and consumers to issue a call for comprehensive r...rnists and other primary care physicians. , Dur...e medicine in the U.S., Dr. Dale and other panelis...
(Date:5/16/2008)...la., May 16 /PRNewswire-USNewswire/- "Huh, what di...mericans, particularly our,children. More than 30 ...e,significant hearing loss and the numbers are gro... school age children have some form of hearing,los...l and economic problem,is what led Kathlyn Maguire...
(Date:5/16/2008)...ndraiser Seeks to Raise $38 Million for Life-threa...-USNewswire/ -- Walkers in nearly,every state will...ay 17 and,18 -- by participating in GREAT STRIDES,...ibrosis Foundation announced today., May is Natio...is is a,life-threatening genetic disease that caus...
(Date:5/16/2008)...Urban Health Institute with 10,000 Sensual O Condo...Playboy Mansion Fundraiser, LOS ANGELES, May 16 /...,and R & B artist J Kwon known best for his hit so...presenting the Urban Health Institute (UHI) with,1...$50,000. The donation is,being made to promote the...
Breaking Medicine News(10 mins):Health News:ACP says major system reforms needed to improve the state of primary care medicine in the US 2Health News:Huh, What Did You Say?: May is 'Better Hearing and Speech Month' 2Health News:Huh, What Did You Say?: May is 'Better Hearing and Speech Month' 3Health News:GREAT STRIDES Walks for Cystic Fibrosis Slated for 47 States This Weekend 2Health News:Everybody in the Club Scream O! 2
...elivered a male child on Wednesday at Holtz Childr... heart disorder called Ectopia// cordis. Seven or ... defect. The baby named Naseem, was born with his...one or sternum and the protective cover for the he...
...verweight children may have sleep problems that re... study which was published in the November issue o... 25 out of 100 overweight, inactive children teste...ng, including telltale snoring. After about three...
...y will be able to answer this question within the ...nternational study called TRIGR// (Trial to Reduce...by University of Helsinki, Finland, will research ...cation may prevent type 1 diabetes later in childh...
...o strengthen fragile, aging bones may also be prot...ed by Johns Hopkins// rheumatologist Clifton Bingh...te might be used to treat osteoarthritis after not...nds in the same class of drugs, not only slowed jo...
Other Medicine News:Health News:Naseem’s Heart Put In Its Plac 2Health News:Overweight Children Tested Positive For Sleep Disorders 2Health News:Overweight Children Tested Positive For Sleep Disorders 3Health News:Can Early Nutritional Modification Prevent Type 1 Diabetes? 2Health News:Millions with Arthritis May Benefit from Bone Loss Drug 2
(Date:5/16/2008)...-- Results demonstrating that TYKERB and trastuzum...tension of progression-free survival (PFS), -- Co...inside and,outside of the HER2 receptor may create...ting activity of TYKERB alone despite patients,pr...b and chemotherapy, LONDON and PHILADELPHIA, May ...
(Date:5/16/2008)...l Biomarkers -- for Lung Cancer Diagnosis and, Ide...r of Unknown Primary ...Types With High Sensitivity and, Specificity and...ncer Results of microRNA Signature to Identify Ti...ding 90% and Specificity of 99%, REHOVOT, Israel ...
(Date:5/16/2008)...al Mechanism May Offer Novel Approach to Blood ...LEANS, May 16 /- Pharmacope...nd development of novel small,molecule therapeutic...ss,Dual Acting Receptor Antagonist (DARA), showed ...s in a Phase 2a study in patients with mild to,mod...
(Date:5/15/2008)...fficacy for Population Most Affected by Disease -,...wswire-FirstCall/ --,Bayer HealthCare Pharmaceutic... ONXX ) today announced that Nexavar(R) (sorafenib...by 47.3 percent (HR=0.68;,p-value=0.014) in patien...cellular carcinoma (HCC), or primary liver cancer ...
Breaking Medicine Technology:GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab) 2GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab) 3GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab) 4GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab) 5GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab) 6GSK Announces Results of First Phase III Trial Evaluating Tykerb(R) (Lapatinib) Plus Herceptin(R) (Trastuzumab) 7Rosetta Genomics to Present Multiple Posters at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) 2Rosetta Genomics to Present Multiple Posters at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) 3Rosetta Genomics to Present Multiple Posters at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) 4Rosetta Genomics to Present Multiple Posters at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) 5Rosetta Genomics to Present Multiple Posters at the 44th Annual Meeting of the American Society of Clinical Oncology (ASCO) 6Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 2Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 3Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 4Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 5Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 6Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 7Pharmacopeia's First-in-Class Investigational Therapy PS433540 Achieves Statistically Significant Reductions in Blood Pressure in Hypertensive Patients 8Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 2Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 3Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 4Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 5Nexavar Significantly Improves Overall Survival by 47 Percent in Asia-Pacific Liver Cancer Study 6A Patients Right to Know 3A Silver Fillings are 50 25 Mercury 5017 1A Patients Right to Know 3A Silver Fillings are 50 25 Mercury 5017 2Virus Shows Some Cancer Killing Abilities 5014 1Virus Shows Some Cancer Killing Abilities 5014 2Virus Shows Some Cancer Killing Abilities 5014 3Drug commonly used to treat bipolar disorder dramatically increases lifespan in worms 1034 1Drug commonly used to treat bipolar disorder dramatically increases lifespan in worms 1034 2Vitamin D Wont Help Prevent Most Cancers 5012 1Vitamin D Wont Help Prevent Most Cancers 5012 2Vitamin D Wont Help Prevent Most Cancers 5012 3
...aracterization and Broad,Neuroprotective Propertie...imental Therapeutics , Neurodegenerative Disease S...te for ALS That Targets Mitochondrial Proteins , M...aceutical,company specializing in the discovery an... announced today that a publication entitled,"Iden...
... AMADEO, one of the,first studies to compare the ...lockers in hypertensive patients with,diabetic ne...of Hypertension, Milan. The results from this stud...significantly greater extent,than losartan.(1) ...ess, Foothills Hospital,in Calgary, Canada said "...
Other Medicine Technology:Trophos Publishes ALS Article in Journal of Pharmacology and,Experimental Therapeutics 2Trophos Publishes ALS Article in Journal of Pharmacology and,Experimental Therapeutics 3Trophos Publishes ALS Article in Journal of Pharmacology and,Experimental Therapeutics 4New Study Shows That telmisartan has Greater Renoprotective,Potential Thanlosartan in Hypertensive Patients With Type 2,Diabetes 2New Study Shows That telmisartan has Greater Renoprotective,Potential Thanlosartan in Hypertensive Patients With Type 2,Diabetes 3New Study Shows That telmisartan has Greater Renoprotective,Potential Thanlosartan in Hypertensive Patients With Type 2,Diabetes 4New Study Shows That telmisartan has Greater Renoprotective,Potential Thanlosartan in Hypertensive Patients With Type 2,Diabetes 5
...ational reference laboratory and a worldwide leade...t. ARUP offers an extensive test menu of highly co...tomic pathology. Owned by the University of Utah, ...of the nation's university teaching hospitals and ...
...ational reference laboratory and a worldwide leade...t. ARUP offers an extensive test menu of highly co...tomic pathology. Owned by the University of Utah, ...of the nation's university teaching hospitals and ...
...ational reference laboratory and a worldwide leade...t. ARUP offers an extensive test menu of highly co...tomic pathology. Owned by the University of Utah, ...of the nation's university teaching hospitals and ...
...ational reference laboratory and a worldwide leade...t. ARUP offers an extensive test menu of highly co...tomic pathology. Owned by the University of Utah, ...of the nation's university teaching hospitals and ...
Medicine Products: